AbstractSecretoneurin is a recently discovered neuropeptide derived from secretogranin II (SgII). Since this peptide could be detected in the dorsal horn of the spinal cord we studied whether it is localized in and released from primary afferent neurons. Secretoneurin was investigated with immunocytochemistry and radioimmunoassay in spinal cord, dorsal root ganglia and peripheral organs. SgII mRNA was determined in dorsal root ganglia. Normal rats and rats pre‐treated neonatally with capsaicin to destroy selectively polymodal nociceptive (C‐) fibres were used. Slices of dorsal spinal cord were perfusedin vitrofor release experiments. Immunocytochemistry showed a distinct distribution of secretoneurin‐immunoreactivity (IR) in the spinal cord and lower brainstem. A particularly high density of fibres was found in lamina I and outer lamina II of the caudal trigeminal nucleus and of the spinal cord. This distribution was qualitatively identical in rat and human post‐mortem tissue. Numerous small diameter and some large dorsal root ganglia neurons were found to contain SgII mRNA. Capsaicin treatment led to a marked depletion of secretoneurin‐IR in the substantia gelatinosa, but not in other immunopositive areas of the spinal cord and to a substantial loss of small (<25 μm) SgII‐mRNA‐containing dorsal root ganglia neurons. Radioimmunoassay revealed a significant decrease of secretoneurin‐IR in the dorsal spinal cord, the trachea, heart and urinary bladder of capsaicin‐treated rats. Perfusion of spinal cord slices with capsaicin as well as with 60 mM potassium led to a release of secretoneurin‐IR. In conclusion, secretoneurin is a neuropeptide which is stored in and released from capsaicin‐sensitive, primary afferent (C‐fibre) neurons. It may, therefore, be a novel peptidergic modulator of pain transmission or of C‐fibre mediated n
展开▼
